Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00120185
Recruitment Status : Completed
First Posted : July 15, 2005
Last Update Posted : December 22, 2011
Chiron Corporation
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis